Lack of β-amyloid cleaving enzyme-1 (BACE1) impairs long-term synaptic plasticity but enhances granule cell excitability and oscillatory activity in the dentate gyrus in vivo.
Action Potentials
/ genetics
Amyloid Precursor Protein Secretases
/ deficiency
Animals
Aspartic Acid Endopeptidases
/ deficiency
Biological Clocks
/ genetics
Biophysics
Dentate Gyrus
/ cytology
Electric Stimulation
Excitatory Postsynaptic Potentials
/ genetics
Male
Mice
Mice, Knockout
Neuronal Plasticity
/ genetics
Neurons
Perforant Pathway
/ cytology
Reaction Time
/ genetics
Time Factors
Alzheimer’s disease
Electrophysiology
LTP
Local field potentials (LFPs)
Population spike
Journal
Brain structure & function
ISSN: 1863-2661
Titre abrégé: Brain Struct Funct
Pays: Germany
ID NLM: 101282001
Informations de publication
Date de publication:
Apr 2019
Apr 2019
Historique:
received:
13
10
2018
accepted:
16
01
2019
pubmed:
1
2
2019
medline:
31
8
2019
entrez:
1
2
2019
Statut:
ppublish
Résumé
BACE1 is a β-secretase involved in the cleavage of amyloid precursor protein and the pathogenesis of Alzheimer's disease (AD). The entorhinal cortex and the dentate gyrus are important for learning and memory, which are affected in the early stages of AD. Since BACE1 is a potential target for AD therapy, it is crucial to understand its physiological role in these brain regions. Here, we examined the function of BACE1 in the dentate gyrus. We show that loss of BACE1 in the dentate gyrus leads to increased granule cell excitability, indicated by enhanced efficiency of synaptic potentials to generate granule cell spikes. The increase in granule cell excitability was accompanied by prolonged paired-pulse inhibition, altered network gamma oscillations, and impaired synaptic plasticity at entorhinal-dentate synapses of the perforant path. In summary, this is the first detailed electrophysiological study of BACE1 deletion at the network level in vivo. The results suggest that BACE1 is important for normal dentate gyrus network function. This has implications for the use of BACE1 inhibitors as therapeutics for AD therapy, since BACE1 inhibition could similarly disrupt synaptic plasticity and excitability in the entorhinal-dentate circuitry.
Identifiants
pubmed: 30701309
doi: 10.1007/s00429-019-01836-6
pii: 10.1007/s00429-019-01836-6
doi:
Substances chimiques
Amyloid Precursor Protein Secretases
EC 3.4.-
Aspartic Acid Endopeptidases
EC 3.4.23.-
Bace1 protein, mouse
EC 3.4.23.46
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
1279-1290Subventions
Organisme : Deutsche Forschungsgemeinschaft
ID : JE 528/6-1
Organisme : Alzheimer Forschung Initiative
ID : 15038